BN
Beyond Next Ventures
Venture CapitalActiveBeyond Next Ventures is a Tokyo-based venture capital firm that invests in mainly medical & Life science field.
48
Investments
3
Exits
$500M
AUM
6.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Beyond Next Ventures.
Investment Thesis & Strategy
Beyond Next Ventures invests in various stages of medical and life science companies, primarily based in Tokyo.
Investment Activity
Deals per year over the last 5 years
1
20180
20191
20206
20214
2022Portfolio Companies
Selected investments from their portfolio of 48 companies
T
Tella
Biotech · Series A, 2022
S
SanRaku
Food & Beverage · Seed, 2022
G
Goryo
Biotech · Seed, 2022
I
InnoTherapy
Biotech · Seed, 2022
C
CureApp
Healthcare · Series C+, 2021
C
CellFiber
Biotech · Seed, 2021
A
Aillis
Healthcare · Series A, 2021
E
Edison
Healthcare · Series A, 2021
E
ELIX Inc.
Biotech · Series A, 2021
M
MedVenture Partners
Healthcare · Series A, 2021
A
Aculys Pharma
Biotech · Series A, 2020
H
Hacarus
AI/ML · Series A, 2018
Notable Exits
CompanyTypeYearValue / Acquirer
TellaAcquisition2023—
CellidIPO2023—
AillisAcquisition2022—
Frequently Asked Questions
Beyond Next Ventures focuses on Series A, Series B, Series C+ stage investments.